Keyphrases
Intestinal Permeability
72%
Prodrug
70%
Bariatric Surgery
62%
Solubility-permeability Interplay
53%
Phospholipids
48%
Lipophilic Drugs
45%
Intestinal Absorption
40%
Prodrug Strategy
36%
Small Intestine
35%
Oral Drugs
33%
Solubility-enabling Formulations
32%
Drug Absorption
32%
Oral Absorption
29%
Oral Drug Delivery
26%
Phospholipase A2 (PLA2)
26%
Drug Delivery
25%
Apparent Solubility
25%
Oral Delivery
24%
Inflammatory Bowel Disease
23%
Metoprolol
23%
Biopharmaceutics
23%
Carbamazepine
22%
Cyclodextrin
22%
Drug Target
22%
Oral Administration
22%
Formulation Development
21%
Gastrointestinal Tract
20%
P-glycoprotein (P-gp)
20%
Single-pass Intestinal Perfusion
19%
Targeted Prodrugs
18%
Indomethacin
18%
High Permeability
17%
Linker
17%
Unstirred Water Layer
17%
Bariatric Patients
17%
Sleeve Gastrectomy
16%
Segmental-dependent Permeability
15%
Colon
15%
Drug Therapy
15%
PEG-400
15%
Pharmacokinetics
14%
BCS Classification
14%
Solubility Increase
14%
Jejunum
14%
Zanamivir
14%
Biopharmaceuticals
13%
Oral Bioavailability
13%
Oral Formulation
13%
Intestine
13%
Permeability Decline
13%
Pharmacology, Toxicology and Pharmaceutical Science
Prodrug
100%
Intestinal Permeability
65%
Bioavailability
61%
Drug Absorption
53%
Phospholipid
45%
Pharmaceutics
40%
Pharmacokinetics
35%
Pharmacotherapy
32%
Inflammatory Bowel Disease
31%
Drug Delivery System
28%
Metoprolol
27%
Oral Drug Delivery
26%
Cyclodextrin
25%
Carbamazepine
24%
Phospholipase A2
22%
Jejunum
20%
Effusion
18%
Indometacin
18%
Drug Solubility
18%
P-Glycoprotein
18%
Dosage Forms
17%
Combination Therapy
17%
Drug Formulation
16%
Ileum
15%
Antivirus Agent
15%
Drug Development
15%
Polyethylene Glycol
14%
Relenza
14%
Amorphous Solid Dispersion
14%
Phytochemical
14%
Ciclosporin
12%
Colchicine
11%
Excipient
11%
Egg Lecithin
10%
Targeted Drug Delivery
10%
Etoposide
10%
Intestinal Drug Absorption
10%
Lamictal
10%
Antiinfective Agent
10%
Drug Discovery
10%
Formulation Design
10%
Surfactant
10%
Progesterone
9%
Parallel Artificial Membrane Permeability Assay
9%
Drug Dose
9%
Malignant Neoplasm
9%
Bioequivalence
8%
Drug Administration
8%
Drug Conjugate
8%
Multidrug Resistance-Associated Protein 2
8%